Evaluation of the stability of Yamakagashi (Rhabdophis tigrinus) Equine Antivenom after 20 years storage
https://doi.org/10.47665/tb.38.2.042
- Author:
Morokuma, K.
1
,
2
;
Matsumura, T.
3
;
Yamamoto, A.
4
;
Sakai, A.
5
;
Hifumi, T.
6
;
Ato, M.
7
;
Takahashi, M.
2
Author Information
1. Kikuchi Quality Control Department, KM Biologics Co., Ltd., 1314-1 Kyokushi Kawabe, Kikuchi-shi, Kumamoto 869-1298, Japan&
2. Toxin and Biologicals Research Laboratory, Kumamato Health Science University, 325 Izumi-machi, Kita-ku, Kumamoto-shi, Kumamoto 861-5598, Japan
3. Department of Immunology, National Institute of Infectious Disease, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
4. Department of Biosafety, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan
5. The Japan Snake Institute, 3318 Yabuzuka, Ota-shi, Gunma 379-2301, Japan
6. Department of Emergency and Critical Care Medicine, St. Lukes International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan
7. Department of Mycobacteriology, National Institute of Infectious Diseases, 4-2-1 Aoba-cho, Higashimurayama-shi, Tokyo 189-0002, Japan
- Publication Type:Journal Article
- Keywords:
Yamakagashi;
Rhabdophis tigrinus;
antivenom;
snake venom;
long term storage
- From:Tropical Biomedicine
2021;38(No.2):111-118
- CountryMalaysia
- Language:English
-
Abstract:
In 2000, an equine Yamakagashi (Rhabdophis tigrinus) antivenom (Lot 0001) was testmanufactured as an unapproved drug for treatment of Yamakagashi bites. It was stocked on the premise of super-legal use from the viewpoint of emergency health crisis management. The antivenom showed a strong neutralizing ability against the hemorrhagic and coagulation activity of the Yamakagashi venom in its potency test. One vial of the antivenom can effectively neutralize at least about 4 mg of Yamakagashi venom. Its efficacy has also been confirmed in patients with severe cases of R. tigrinus bite that has been used in emergency. In 2020, this antivenom (Lot 0001) has reached 20 years after its production. To evaluate the integrity and potency of the antivenom, quality control, safety and potency tests had been conducted almost every year since 2012. Physical and chemical tests (property test, moisture content test, insoluble foreign matter test, osmotic pressure ratio test, pH test, protein content test, endotoxin test, sterility test) of the antivenom, showed no significant changes throughout the years, when compared to the results immediately after its production in 2000. All the parameters measured were also within the standard values. In animal safety tests (test for absence of toxicity and pyrogen), there was no change in the test results during the storage period and no abnormalities were observed. The potency test (anti-coagulant activity) after 20 years of the product, showed the same potency as those recorded immediately after production. Therefore, in all of the stability monitoring tests conducted so far, the product did not show any significant change compared to the results immediately after production. This confirms the stability of the product during the stockpiling period to the present, that is, 20 years after production.
- Full text:8.2021my1245.pdf
